ArticleClinical and experimental nephrology2025
Age and gender differences in the urinary proteome of healthy subjects using the advantages of quantitative proteomics.
Article in Clinical and experimental nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvances in quantitative proteomics have enabled accurate and comprehensive quantification of proteins. In this study, urine from healthy volunteers was analyzed using this method to confirm the depth of protein identification and quantitative stability, and to examine changes in abundance with age and sex, as well as the amounts of proteins known to be urinary biomarkers of kidney damage.
methodsUrine samples were collected from 89 healthy male and female volunteers in their 20s to 70s. Proteins were precipitated with methanol/chloroform, digested with trypsin, and peptides were identified and quantified by mass spectrometry. The quantitative relative value of a protein in the total protein was multiplied by 1,000,000 to obtain a normalized relative value (ppm). The stability of the quantitative proteomics was examined by measuring quality control samples prepared from healthy volunteer urine mix (HVmix) or diabetic urine mix (DMmix) 5 times in every 20 sample measurements.
resultsThe number of proteins identified was stable at approximately 3000 in five measurements of HVmix and DMmix, as quality control samples. The average coefficient of variation (CV) of the quantitative values was 12.6% for HVmix and 14.8% for DMmix. Approximately 90% of the proteins did not change significantly with age, while approximately 10% of the proteins increased or decreased with age. The quantitative values of some proteins, such as KLK3 in men and A2ML1 in women, differed significantly between the sexes. In addition, several proteins that have already been reported as biomarkers of kidney damage were also quantified. CONCLUSION(S): This study demonstrated that advanced proteomics enabled comprehensive quantification of urinary proteins, some proteins varied in abundance with age and gender, and provided insight into protein structure.
Indexed as
Identifiers
39992494What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.